Stay updated on NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Results for the study were posted, including progression-free survival, objective response rate, and safety data. The study record dates were updated to reflect the availability of results.
    Difference
    0.4%
    Check dated 2025-11-03T11:39:46.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Additions substantially update the study description with precise dosing, duration, endpoints, and reporting dates; deletions remove the older, shorter phrasing. Overall, the page content has been significantly expanded and clarified.
    Difference
    8%
    Check dated 2025-10-20T05:37:00.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Additions introduce a government funding notice and confirm the NIH Clinical Center is open, plus a v3.2.0 revision; deletions remove v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T16:39:51.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T09:55:45.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing the previous v3.0.1. Additionally, the Back to Top link was removed, a minor navigational change with little impact on core content.
    Difference
    0.2%
    Check dated 2025-09-14T00:13:40.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T21:04:35.000Z thumbnail image

Stay in the know with updates to NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NIVO-IPI-TAXANE in Metastatic NSCLC Clinical Trial page.